| View |
2022-12-29-0367
|
PURIFIED RABIES VACCINE (VERO CELL)
|
SPEEDA
|
BR-669
|
202201009AX
|
Packaging Lot (Box and Vial): 202201009AX; (Diluent): 28220303-1
|
6-Jan-25
|
05 January 2023
|
| View |
LRV2024-03-05-0078
|
TETANUS TOXOID
|
BIO-TT
|
BR-663
|
281822
|
Packaging Lot (Box and Ampoule): 0281822
|
6-Jul-25
|
11 March 2024
|
| View |
LRV2023-12-19-0389
|
MEASLES, MUMPS RUBELLA AND VARICELLA (OKA/MERCK) VIRUS VACCINE LIVE
|
PROQUAD
|
BR-1089
|
1640202
|
Packaging Lot (Box, Vial and Pre-filled Syringe [Diluent]): X025360
|
6-Mar-25
|
22 December 2023
|
| View |
2023-07-26-0248
|
BACILLUS CALMETTE-GUERIN (BCG) VACCINE
|
-
|
BR-596
|
202211a038
|
Packaging Lot: (Box and Ampoule): 202211a038; (Diluent): 01220503-2
|
6-Nov-24
|
28 July 2023
|
| View |
2023-05-09-0163
|
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
|
HEPABIG
|
BR-334
|
230H21007
|
Packaging Lot: (Box and Vial): 230H21007
|
6-Oct-23
|
15 May 2023
|
| View |
2023-04-24-0141
|
MEASLES, MUMPS RUBELLA AND VARICELLA (OKA/MERCK) VIRUS VACCINE LIVE
|
PROQUAD
|
BR-1089
|
1561769
|
Packaging Lot: (Box, Vial and Pre-filled Syringe [Diluent]): X006670
|
6-Sep-24
|
28 April 2023
|
| View |
2023-07-12-0217
|
JAPANESE ENCEPHALITIS VACCINE (LIVE, ATTENUATED)
|
IMOJEV
|
BR-923
|
08C2211-1
|
Packaging Lot: (Box): (1) 08C2211JB, (Box): (2) 08C2211JC; (Vial): 08C2211-1; (Diluent): (1) 14A2222-2; (Diluent): (2) 14A2301-1; (Syringe 1cc/mL): (1) 211308 D; (Diluent): (2) 211203 D; (Needle 23G x 1"): 2206020; (Needle 25G x 5/8"): 2205064
|
6-Sep-26
|
18 July 2023
|
| View |
2021-07-05-0320
|
PURIFIED RABIES VACCINE (VERO CELL)
|
SPEEDA
|
BR-669
|
202012455
|
Packaging Lot (Box & Vial): 202012455; (Diluent): 28200903-3
|
7 December 2023
|
8 July 2021
|
| View |
2022-06-07-0143
|
SHINGLES (HERPES ZOSTER) VACCINE (LIVE)
|
V-Z VAX
|
BR-388
|
S50122002
|
Packaging Lot (Box & Vial): S50122002; (Diluent): S70222001
|
7 February 2024
|
10 June 2022
|
| View |
2021-07-26-0369
|
RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR
|
EASYEF
|
BR-881
|
B01862A
|
Packaging Lot (Box & Plastic Air-container): B01862A
|
7 January 2023
|
27 July 2021
|
| View |
2022-02-16-0041
|
PNEUMOCCOCCAL POLYSACHARIDE VACCINE, POLYVALENT
|
PNEUMOVAX 23
|
BR-1147
|
1358148
|
Packaging Lot (Box & Pre-filled Syringe): U040538
|
7 July 2023
|
18 February 2022
|
| View |
2022-10-20-0306
|
HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
|
GARDASIL
|
BR-603
|
1411956
|
Packaging Lot (Box & Vial): W026416
|
7 November 2024
|
26 October 2022
|
| View |
2023-05-10-0164
|
HUMAN NORMAL IMMUNOGLOBULIN
|
I.V. - GLOBULIN SN INJECTION
|
BR-469
|
357B23002
|
Packaging Lot: (Box and Vial): 357B23002
|
7-Aug-25
|
15 May 2023
|
| View |
LRV2023-12-28-0403
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IV-GLOBULIN SN INJECTION
|
BR-897
|
358R23005
|
Packaging Lot (Box and Vial): 358R23005
|
7-Feb-26
|
04 January 2024
|
| View |
2023-06-29-0196
|
HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
|
GARDASIL
|
BR-602
|
X013071
|
Packaging Lot: (Box and Pre-filled Syringe): X013071; (Needle 25G x 1"): 2301057; (Needle 23G x 1"): 2210026, 2209019
|
7-Mar-26
|
06 July 2023
|
| View |
LRV2024-04-18-0144
|
VARICELLA VIRUS VACCINE, LIVE
|
VARIVAX
|
BR-955
|
1656861
|
Packaging Lot (Box, Vial and Diluent): Y005527
|
7-Mar-26
|
24 April 2024
|
| View |
2023-05-29-0176
|
HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
|
GARDASIL
|
BR-603
|
27-Oct-07
|
Packaging Lot (Box and Vial): X008318
|
7-Nov-25
|
31 May 2023
|
| View |
LRV2024-12-12-0532
|
VARICELLA VIRUS VACCINE, LIVE
|
VARIVAX
|
BR-955
|
1773444
|
Packaging Lot (Box, Vial and Diluent): Y018488
|
7-Nov-26
|
18 December 2024
|
| View |
2023-03-13-0082
|
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE (RECOMBINANT, ADSORBED)
|
GARDASIL 9
|
BR-1168
|
1563835
|
Packaging Lot (Box and PFS): X002990; (Needle 23G x 1"): 2207004; (Needle 25G x 1"): 2208047
|
7-Oct-25
|
17 March 2023
|
| View |
2021-07-28-0376
|
PNEUMOCCOCCAL POLYSACHARIDE VACCINE, POLYVALENT
|
PNEUMOVAX 23
|
BR-1147
|
1291454
|
Packaging Lot (Box & PFS): U017188
|
8 February 2023
|
30 July 2021
|